Peripheral neuropathy in alcoholics is usually attributed to a lack of aneurin (Victor and Adams, 1961) ; however, it is often not possible to document this relation by diagnostic or therapeutic tests. Demonstration that pantothenic acid (Hodges et al., 1958) or pyridoxine (Biehl and Vilter, 1954) deficiency may cause peripheral nerve dysfunction suggests that lack of these or other B-complex vitamins may also contribute to neuropathy in the malnourished alcoholic. The present investigation was therefore undertaken to evaluate further the role of aneurin and other B-complex vitamins in the development of this condition. The study consisted of (a) determining circulating levels of aneurin, riboflavin, nicotinic acid, pantothenic acid, biotin, pyridoxine, vitamin BI2, and folic acid in alcoholic patients with and without neuropathy; and (b) an evaluation of the responsiveness of patients with neuropathy to various members of the B-complex group.
Materials and Methods
Studies were conducted on 20 healthy volunteers and 49 in-patients with a history of chronic alcoholism, 32 of whom had evidence of peripheral neuropathy. Each of the patients with alcoholism had a history of prolonged dietary inadequacy; 16 were admitted to hospital because of peripheral neuropathy, 16 because of symptoms incident to liver disease, 12 because of active or impending delirium tremens, 3 because of pneumonia, and 2 because of pancreatitis. History revealed that none of the 32 patients with peripheral neuropathy had normal dietary habits (grade 1), 12 had eaten well except during drinking bouts (grade 2), 14 had ingested diets grossly deficient in animal and vegetable proteins (grade 3), and 6 had principally eaten carbohydrate-containing foods for prolonged periods (grade 4). Estimation of alcohol consumption revealed that seven patients drank alcoholic beverages in moderate quantity, not exceeding a total of 2 pints (1,140 ml.) of whisky or its equivalent each week (grade 1); 10 patients consumed an equivalent 1 to 2 pints (570-1,140 ml.) of whisky daily for several days or weeks followed by a remission (grade 2), and 12 patients were chronic users of alcohol, consuming an equivalent of 1 to 2 pints (570-1,140 ml.) of whisky daily for several months, or until admitted to hospital (grade 3). Physical examination revealed clinical stigmata of liver disease in 18 patients with peripheral neuropathy and 10 patients without peripheral neuropathy. Five patients had Wernicke's encephalopathy, 5 had clinical evidence of pellagra, 12 had tongue signs of nicotinic acid or riboflavin deficiency, and 2 had ocular signs of riboflavin deficiency.
Fourteen (Malloy and Evelyn, 1937) , sulphobromophthalein excretion (Mendenhall and Leevy, 1961) , serum alkaline phosphatase (Bodansky, 1933) , cephalin flocculation test (Hanger, 1938) , serum transaminases (Wroblewski and LaDue, 1956) , and serum proteins (Campbell and Hanna, 1937) . Liver biopsy was performed with the Vim-Silverman needle without complications. B-complex vitamin levels were determined by microbiological techniques employing Ochromonas danica for aneurin and biotin; Tetrahymena pyriformis for riboflavin, nicotinic acid, and vitamin B6 complex; Lactobacillus arabinosus for pantothenic acid; Ochromonas maihamensis for vitamin B12 ; and Lactobacillus casei for folic acid (Baker and Sobotka, 1962) . Selected patients had measurement of muscle and urinary aneurin, estimation of red-bloodcell transketolase activity (Brin et al., 1958) , and measurement of blood keto-acids (Friedmann and Haugen, 1943) .
Responses to vitamin therapy were evaluated in 29 patients with neuropathy (see Table) . These patients were treated in the Clinical Research Center or a special rehabilitation ward, and received a diet containing 700 mJAg. of aneurin, 20 m/sg. of nicotinic acid, 250 mpug. of pantothenic acid, 50 mtug. of pyridoxine, 5 m/sg. of folic acid, and 45 ,tg. of vitamin B12. Aneurin 10 mg. was given intramuscularly each day and serial observations were made on the effect of this treatment on neuropathy. Patients with a decrease in circulating levels of nicotinic acid, pantothenic acid, pyridoxine, folic acid, and/or vitamin Bi2 who failed to show improvement in neurological status after 10 days of aneurin therapy were treated with the deficient vitamin. Fifty mg. of nicotinic acid, 200 mg. of pantothenic acid, or 50 mg. of pyridoxine was first given daily on an individual basis according to a predetermined randomized schedule. Daily supplements of 5 mg. of folic acid and 1,000 [kg. of vitamin B12 were finally added to the therapeutic regimen.
Results
The blood aneurin was significantly lower than normal in 44% of alcoholic patients without neuropathy, and in 86.2% of patients with neuropathy. The mean blood aneurin was 43+ 17.2 mug./ml. in normal subjects, 25 + 11 mpg. in alcoholics without neuropathy, and 14.1 + 9.6 mug. in alcoholics with neuropathy ( Fig. 1) . Low blood aneurin was regularly associated with reduced urinary excretion of aneurin and decreased muscle content of this vitamin. A good correlation was noted between red-blood-cell transketolase activity and blood aneurin in subjects without significant liver disease; enzyme and vitamin levels often showed no relation in aneurindeficient patients with cirrhosis (Fennelly et al., 1963) . A low serum folic acid was the second most frequently encountered abnormality, being present in 61 % of those without neuropathy and 69% of those with neuropathy. Low circulating biotin, vitamin B6, pantothenic acid, riboflavin, and vitamin B12 were encountered in 31%, 24%, 18%, and 10% respectively of alcoholics with neuropathy (Fig. 2) . Combined vitamin B deficiencies were present in 90% of patients with peripheral neuropathy. A low aneurin was accompanied by a significant reduction in folic acid in 45%, nicotinic acid in 42%, biotin in 24%, vitamin B6 in 24%, riboflavin in 17%, pantothenic acid in 14%, and vitamin B12 in 10% of patients. Vitamin levels were lowest in patients exhibiting clinical stigmata of deficiency. Patients with Wernicke's encephalopathy had aneurin levels of 2.5, 3, 6, 7, and 10 /.tg./ml. Two patients with corneal changes attributed to riboflavin deficiency had blood riboflavin levels of 13 and 39 mjug./ml. Patients with diarrhoea, encephalopathy, or skin changes compatible with pellagra had a mean blood nicotinic acid level of 2.6 ,jg./ ml. Seventy per cent. of patients with a low serum folic acid had macrocytosis, anaemia, and/or bone-marrow changes compatible with folic-acid deficiency.
There was no correlation between circulating vitamin levels and severity of alcoholism. The mean blood aneurin level in patients with grade 1 alcoholic consumption was 17 ptg./ml.; in those classified as grade 2 alcoholic consumption it was 18 /Ag./ml.; and in those classified as grade 3 alcoholic consumption it was 17 ttg./ml. In contrast, a direct relation was noted between hypovitaminaemia and dietary deficiency. The most marked reduction in circulating vitamin levels occurred in patients subsisting principally on alcoholic beverages and carbohydrate-containing foods. Mean blood aneurin level in patients with a dietary intake classified as grade 1 was 27 m/ig./ml., in those classified as grade 2 it was 13 m/Ag./ml., in those classified as grade 3 it was 14 mtsg./ml., and in those classified as grade 4 it was 10 m~ug./ml.
Mean circulating levels of aneurin, riboflavin, nicotinic acid, biotin, and vitamin B, were lower in malnourished alcoholics with fatty liver and cirrhosis than those with normal liver ). An increase in serum pantothenic acid was often present in fatty liver, whereas an increase in serum vitamin B12 occurred with active liver-cell necrosis. Response to the therapeutic programme depended upon the severity of neuropathy and presence or absence of severe cirrhosis. Aneurin replacement caused marked improvement in signs of neuropathy in 7 out of 13 patients with grade I neuropathy, and in three out of eight patients with grade II neuropathy within a four-week period (see Table) . In these patients, symptoms, pain, and vibratory sensations began to improve within 7 to 10 days. Aneurin caused slower but definite improvement in one patient with grade I neuropathy and in one with grade II neuropathy. None of the patients with grade III neuropathy showed clinical improvement during the initial four-week period of treatment ; four out of eight showed improvement after three to six months of therapy. Three patients with grade I neuropathy, four with grade II neuropathy, and four with grade III neuropathy did not respond to aneurin. This was attributed to the presence of a deficiency of other vitamins in five patients, the presence of severe liver disease, and inability to utilize administered aneurin in four patients (Fennelly et al., 1964) , and the irreversibility of neuropathy in two patients. Disappearance of signs and symptoms of neuropathy refractory to aneurin therapy occurred after correction of a low circulating nicotinic acid in two patients with grade I neuropathy and one patient with grade II neuropathy. Identical effects were noted after correction of a low serum pantothenic acid in a patient with grade I neuropathy, and after restoration of a normal vitamin B., level in a patient with grade II neuropathy.
Discussion
The present study confirms the primary aetiological role of aneurin deficiency in peripheral neuropathy of the alcoholic and indicates that a decreased pantothenic acid, nicotinic acid, or pyridoxine may also be responsible or contributory. These findings emphasize the importance of measuring all vitamins whenever possible and replacing those that are deficient in alcoholics with peripheral neuropathy. Decreased serum vitamin Bi,' was often present ; however, there was no evidence from therapeutic trials that a deficiency of this vitamin caused neuropathy in this group of patients. Similarly, therapeutic responses suggested that encountered deficiencies of folic acid, riboflavin, or biotin were also not responsible for nerve damage.
Pantothenic acid, pyridoxine, and nicotinic acid deficiency have previously been demonstrated to be important in the development of peripheral neuropathy in non-alcoholic patients. Experimental pantothenic acid deficiency induced by omegamethyl-pantothenic acid is characterized by burning feet (Hodges et al., 1958) ; moreover, the symptom of neuropathy in malnourished Indians is controlled by treatment with pantothenic acid (Gopalan, 1946) . Inhibition of pyridoxine activity is responsible for isoniazid-induced neuropathy (Biehl and Vilter, 1954) , and a deficiency of nicotinic acid appears to be aetiological in thalidomide-induced peripheral neuritis (Robertson, 1962 ; Frank et al., 1963) . Their aetiological role should be expected, since they are often absent from the diet of alcoholics with peripheral neuropathy .
The occasional presence of lower circulating levels of Bcomplex vitamins in alcoholics without neuropathy than in those with nerve damage suggests that other factors may contribute to nerve dysfunction. It is possible that observed laboratory evidence of vitamin deficiency was not present long enough to cause nerve impairment in alcoholics without neuropathy. Alternatively, nerve damage may be due to a combination of a vitamin deficiency and other factors such as protein or mineral deficiency and alcohol toxicity. 
